Cadila Healthcare has informed that it has enclosed a copy of press release dated July 18, 2020 titled ‘Zydus Cadila receives final approval from USFDA for Butalbital, Acetaminophen and Caffeine Tablets’ .The contents of the press release give full details. Bring the aforesaid news to the notice of the members of the exchange and the investors’ at large.
The above information is a part of company’s filings submitted to BSE.